| abstract |
FIELD: medicine, pharmacy. n SUBSTANCE: invention relates to pharmaceutical or dietetic composition for reducing level of IGF-I in mammal blood that involves effective amount of carotinoid lycopene reducing the level of IGF-I. Also, invention provides reducing levels of IGF-I that involves administration in subject of lycopene in effective dose, if necessary, and reducing the level of IGF-I. The advantage of invention involves the development of preparation reducing the level of IGF-I in mammal blood effectively. n EFFECT: valuable properties of composition. n 14 cl, 1 dwg, 1 ex |